News Agency
The Times

Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment

  • Written by Media Outreach
  • Heidelberg Pharma grants Huadong exclusive license to develop and commercialize HDP-101 and HDP-103 in Asia[1] (excluding Japan), plus exclusive opt-in rights for two more pipeline candidates, with a total deal value of up to USD 930 million (EUR 825 million)
  • Huadong will also participate in a rights issue and acquire a percentage of...

Read more: Heidelberg Pharma and Huadong Announce Strategic Partnership, Including Equity Investment

How Can Businesses Reduce the Risk of Commercial Litigation?

Commercial disputes often begin with a misunderstanding, an unclear contract or a delayed response to a growing problem. Seeking early advice from Litigation Lawyers Sydney with PCL lawyers can help businesses trust and identify legal risks, clarify obligations and create a strategy... Read more

Writers Wanted



NewsServices.com

Content & Technology Connecting Global Audiences

More Information - Less Opinion